Blog

IVIG

Does IVIG Cause Fluid Retention?

Woman with IVIG fluid retention in her left foot

Fluid retention is a condition that occurs when the body is unable to maintain its fluid balance. As a result, excess fluid accumulates or is trapped inside the body’s tissues. This condition is known as edema, and it is often restricted to particular locations, affecting any body area, such as the legs, ankles, feet, or hands.

Ask About IVIG Home Infusion

(877) 778-0318

Does IVIG cause fluid retention? IVIG therapy, which is a life-saving treatment for several inflammatory and immune-related disorders, can cause fluid retention in certain patients with other underlying conditions, such as heart and kidney problems.

Let’s review how IVIG therapy can cause fluid retention, what its initial symptoms are, and how you can manage this side effect.

IVIG and Fluid Retention: Basic Understanding

Generally, your body controls and regulates fluid (water) balance via a complex system. Hormonal factors, the liver, kidneys, cardiovascular system, and urinary system, all work together within this system to maintain fluid balance.

However, if there is a problem with any component of this system, your body fails to expel excess fluid as it should. When this happens, fluid starts to build up within the body’s tissues, causing swelling or puffiness in certain areas of the body, such as the legs or feet.

How IVIG Can Cause Fluid Retention

Fluid retention is one of the common side effects of IVIG therapy. Certain patients who received IVIG therapy experience fluid retention due to the following factors: 

The Volume of IVIG Infusion

IVIG products contain large amounts of fluid, and depending on the prescribed dose and the patient’s weight, a significant volume of IVIG solution may be administered into the bloodstream. The higher the dose, the larger the volume of fluid that is delivered into the patient’s bloodstream.

For patients with heart and kidney problems, IVIG administered in larger doses does cause fluid retention because the extra fluid volume leads to fluid overload due to their organs not working properly. This disturbs the fluid balance in their body, leading to fluid accumulation in the body’s tissues.

Osmotic Load and Protein Content

Man on bed receiving IVIG therapy at home

Since IVIG solutions contain a high concentration of immunoglobulin G (IgG), the large amount of IgG antibodies exerts an osmotic pressure, which alters the fluid balance between blood vessels and tissues.

The high osmotic pressure causes fluid shift from the surrounding tissues into the bloodstream, leading to increased blood volume and fluid overload. In certain patients, this contributes to fluid retention when their heart and kidneys are unable to eliminate excess fluid from the body.

Immune Response and Inflammation

IVIG therapy may cause fluid retention due to the immune response it triggers. This therapy usually initiates an immune response that includes mild inflammation. The inflammation causes capillary leakage, resulting in fluid moving from small blood vessels into surrounding tissues, which leads to swelling.

Impaired Kidney Functions

Patients with impaired kidney functions are more likely to experience fluid retention during or after Paggamot ng IVIG. Since their kidneys do not function properly, they fail to remove excess fluids, which results in fluid retention in their body’s tissues.

Kumuha ng IVIG Copay Assistance

Kumonsulta sa IVIG Specialist

What Are the Signs and Symptoms of Fluid Retention?

The following are some common signs and symptoms of fluid retention that you may experience during or after IVIG treatments:

  • Pagtaas ng timbang
  • Swelling in the legs, ankles or feet
  • Kinakapos na paghinga
  • Decreased urine output
  • Abdominal discomfort

Who Is at High Risk of Fluid Retention During or After IVIG Therapy?

IVIG therapy may cause fluid retention in those who:

  • Have a history of heart failure and kidney disease 
  • Are older adults
  • Are prescribed high dosages of IVIG infusions (a few hundred milliliters to several liters)

How Can You Manage Fluid Retention During or After IVIG Therapy?

You or your healthcare provider can take the following precautions to avoid fluid retention during or after IVIG therapy:

Monitor Fluid Intake and Output

You can monitor fluid intake and output during IVIG infusion to ensure your body processes IVIG solutions properly. However, if you see any unusual changes, such as decreased urination or swelling in feet or ankles, immediately consult your doctor.

Adjust Infusion Rate

You can adjust your infusion rate to avoid fluid overload. For example, slowing down the infusion in patients with heart or kidney problems can prevent the risk of fluid retention from IVIG by giving the body more time to eliminate excess fluids.

Mga gamot

In some cases, diuretic medications are prescribed to patients with heart or kidney diseases to manage fluid retention. Diuretics help the kidneys remove excess fluid and sodium from the body and into the urine, preventing fluid accumulation in the body’s tissues.

Kumuha ng Paunang Awtorisasyon ng IVIG

(877) 778-0318

Konklusyon

It is important to always consult your healthcare provider before receiving IVIG therapy, especially if you have a history of kidney disease or heart failure. This way, your healthcare provider can optimize your treatment plan to reduce the risk of fluid retention during IVIG therapy. 

Understanding that IVIG may cause fluid retention helps patients and providers take proactive measures to manage this side effect.

MGA SANGGUNIAN:

  1. Arumugham, V. B., & Rayi, A. (2023, July 3). Intravenous immunoglobulin (IVIG). StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK554446/#:~:text=%5B76%5D%20The%20most%20common%20of,or%20hypertension%2C%20and%20fluid%20overload.
  2. Duff, K. (2006). You can make a difference in the administration of intravenous immunoglobulin therapy. Journal of Infusion Nursing, 29(3), S5-S14.
  3. Cheng, M. J., & Christmas, C. (2011). Special Considerations with the Use of Intravenous Immunoglobulin in Older Persons. Drugs & Aging, 28(9), 729–736. https://doi.org/10.2165/11592740-000000000-00000
  4. Suzuki, H., Takeuchi, T., Minami, T., Shibuta, S., Uemura, S., & Yoshikawa, N. (2003). Water retention in the acute phase of Kawasaki disease: relationship between oedema and the development of coronary arterial lesions. European Journal of Pediatrics, 162(12), 856–859. https://doi.org/10.1007/s00431-003-1326-4
  5. Majeski, C., Taher, M., Grewal, P., Dytoc, M., & Lauzon, G. (2005). Combination of oral prednisone and intravenous immunoglobulin in the treatment of scleromyxedema. Journal of Cutaneous Medicine and Surgery, 9(3), 99–104. https://doi.org/10.1007/s10227-005-0137-9
Ang impormasyong ito ay hindi kapalit ng medikal na payo o paggamot. Makipag-usap sa iyong doktor o tagapagbigay ng pangangalagang pangkalusugan tungkol sa iyong kondisyong medikal bago magsimula ng anumang bagong paggamot. Ang AmeriPharma® Specialty Care ay walang anumang pananagutan para sa impormasyong ibinigay o para sa anumang diagnosis o paggamot na ginawa bilang isang resulta, at hindi rin ito responsable para sa pagiging maaasahan ng nilalaman. Ang AmeriPharma® Specialty Care ay hindi nagpapatakbo ng lahat ng mga website/organisasyon na nakalista dito, at hindi rin ito responsable para sa pagkakaroon o pagiging maaasahan ng kanilang nilalaman. Ang mga listahang ito ay hindi nagpapahiwatig o bumubuo ng isang pag-endorso, sponsorship, o rekomendasyon ng AmeriPharma® Specialty Care. Ang webpage na ito ay maaaring maglaman ng mga reference sa brand-name na mga inireresetang gamot na mga trademark o rehistradong trademark ng mga pharmaceutical manufacturer na hindi kaakibat sa AmeriPharma® Specialty Care.
MEDICALLY REVIEWED NI Dr. Samantha Kaeberlein, PharmD

Si Dr. Samantha Kaeberlein, PharmD ay ipinanganak at lumaki sa Canton, OH. Natanggap niya ang kanyang pharmacy degree mula sa Northeast Ohio Medical University (NEOMED) noong 2020. Ang pinaka-kasiya-siyang bahagi ng kanyang trabaho ay ang pagbibigay ng medikal na patnubay upang ang mga pasyente ay makagawa ng matalino at mahusay na mga desisyon tungkol sa kanilang pangangalagang pangkalusugan. Ang kanyang mga lugar ng kadalubhasaan ay geriatrics at pangmatagalang pangangalaga. Sa kanyang libreng oras, nasisiyahan siyang gumugol ng oras sa labas, pagbabasa, at pangangaso para sa pinakamagandang tasa ng kape sa America.

Makipag-ugnayan sa Amin

Gamitin ang form na sumusunod sa HIPAA sa ibaba upang humiling ng refill ng iyong reseta. Kung mayroon kang anumang mga katanungan tungkol sa iyong gamot o kung paano ito ibibigay, mangyaring bisitahin ang pahina ng Makipag-ugnay sa Amin o tawagan kami sa (877) 778-0318.

HIPAA Compliant

Sa pamamagitan ng pagsusumite, sumasang-ayon ka sa AmeriPharma's Mga Tuntunin sa Paggamit, Patakaran sa Privacy, at Paunawa ng Mga Kasanayan sa Pagkapribado

tlTagalog